{
    "clinical_study": {
        "@rank": "21621", 
        "arm_group": [
            {
                "arm_group_label": "Enseal", 
                "arm_group_type": "Experimental", 
                "description": "Tissue sealing with Enseal device"
            }, 
            {
                "arm_group_label": "Supracervical hysterectomy using conventional instruments", 
                "arm_group_type": "Active Comparator", 
                "description": "Supracervical hysterectomy using conventional instruments"
            }
        ], 
        "brief_summary": {
            "textblock": "The use of the EnSeal\u00ae instrument for laparoscopic supracervical hysterectomy in a\n      randomized, single-blinded comparison to the conventional procedure. The objective of the\n      study is to investigate if the use of the Enseal sealing instrument for supracervical\n      hysterectomy leads to a shortening of the operation time."
        }, 
        "brief_title": "Use of the Enseal Intrument for Laparoscopic Supracervical Hysterectomy", 
        "completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "condition": "Indications for Laparoscopic Supracervical Hysterectomy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age >18 years\n\n          -  Indication for supracervical hysterectomy without additional surgical procedures (i.\n             e. oophorectomy)\n\n          -  Willingness and capability to comply with all study tests, procedures, and assessment\n             tools\n\n          -  Capability of providing informed consent.\n\n        Exclusion Criteria:\n\n          -  History of, or evidence of, gynecologic malignancy within the past five years\n\n          -  Pace maker, internal defibrilator/cardioconverter\n\n          -  Impaired coagulation parameters\n\n          -  Unwillingness to be randomized to treatment\n\n          -  History of median laparotomy\n\n          -  Intraabdominal adhesions\n\n          -  Requirement for open laparoscopy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01806012", 
            "org_study_id": "05022013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Enseal", 
                "intervention_name": "Sealing tissue with the Enseal device", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Supracervical hysterectomy using conventional instruments", 
                "intervention_name": "Conventional supracervical hysterectomy", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Supracervical Hysterectomy", 
            "Leiomyomas", 
            "Adenomyosis"
        ], 
        "lastchanged_date": "March 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "T\u00fcbingen", 
                    "country": "Germany", 
                    "zip": "72076"
                }, 
                "name": "University Women' Clinic T\u00fcbingen"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Use of the Enseal Intrument for Laparoscopic Supracervical Hysterectomy: a Randomized, Single-Blinded Study Comparing the Efficacy to the Routine Procedure", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The following times were documented: total operation time; T1 = start of the operation until cornual structures were ready to be dissected; T2 = the time from the first coagulation and cutting of the cornual structures until the complete preparation of each parametrial side directly before cervical detachment; T3 = time needed for the cervical detachment and subsequent steps (morcellation, closure of trocar sites) until the end of the surgical procedure.", 
            "measure": "Operation time", 
            "safety_issue": "No", 
            "time_frame": "Day 1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01806012"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital Tuebingen", 
            "investigator_full_name": "Bernhard Kraemer", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The perioperative blood loss (\u0394Hb) was calculated using the comparison of the preoperative red blood cells (RBC) versus the RBC on the first post-operative day. The intraoperative blood loss was measured by the suction unit (categories: < 50 ml, 50 - 100 ml, > 100 ml) and by the number of applied blood transfusions.", 
                "measure": "Blood loss", 
                "safety_issue": "No", 
                "time_frame": "Day 2"
            }, 
            {
                "description": "Post-operative pain was documented according to a visual analog pain scale from 1 (no pain) to 10 (maximum pain) during hospital stay.", 
                "measure": "Post-operative pain", 
                "safety_issue": "No", 
                "time_frame": "Day 2"
            }
        ], 
        "source": "University Hospital Tuebingen", 
        "sponsors": {
            "collaborator": {
                "agency": "Ethicon Endo-Surgery (Europe) GmbH", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "University Hospital Tuebingen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}